QIPT News & Events

The major averages had a down day as markets enter the final full trading week of 2025, with investors responding to recent rally attempts and bouts of tech selloff pressure.Last week's mixed performance and rotation suggests investors are beginning to weigh earnings fundamentals more heavily than lofty growth multiples. Treasury yields have moved sideways after recent volatility, and risk appetite seems to be stabilizing, but only tentatively, as incoming economic indicators and central-bank decisions in both the U.S. and Europe remain key catalysts.Gold prices were fractionally higher as the commodity once again reaches for record highs, while oil finished lower.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Intelis in discussions to acquire SambaNova for $1.6B,ServiceNowis close to a $7B deal for Armis,CencoraOneOncology from TPGfor $6BiRobotentered into ato be acquired by PiceaLuminarinitiatedand agreed to sell its photonics business to Quantum Computingfor $110M2. WALL STREET CALLS:Texas Instrumentsto Sell from Buy at Goldman SachsAkamaito Overweight from Underweight at KeyBancAdobeto Underweight at KeyBancServiceNowto Underweight at KeyBancGoldman SachsLas Vegas Sands, Marriottand Hiltonto Buy as the firm adjusted ratings in the gaming and lodging group as part of its 2026 outlook3. AROUND THE WEB:Xeroxis working on a debt financing that would use its IP as collateral,A collaboration between Matteland Microsoft-backedOpenAI won't emerge this year,Nvidiahas told some Chinese clients that it is evaluating adding production capacity for its H200 AI chips after orders exceeded its output levels,TPGhas exited most of its $600M stake in Anastasia Beverly Hills as part of a debt restructuring,U.S. District Judge George Wu in California ruled Live Nationand its subsidiary Ticketmaster must face a class action for allegedly overcharging its customers for events at major venues across the country,4. MOVERS:Kyverna Therapeuticsincreases after announcing data from itsImmunomegains after announcing its RINGSIDE trial metZIMhigher in New York after announcingto vote 'FOR' all eight of the company's director nomineesCritical Metalsfalls afterfrom its 2024 drilling program at the Tanbreez Rare Earth ProjectZillowand CoStarlower as Google5. EARNINGS/GUIDANCE:Quipt Home Medical, with CEO Gregory Crawford commenting, "Our fiscal 2025 performance underscores both the durability of our model and the accelerating momentum"Highway Holdings, with EPS and revenue lower year-over-yearOcean PowerreportedEdesa Biotechreported, with EPS missing consensusEnWave, with EPS and revenue higher year-over-yearINDEXES:The Dow fell 41.49, or 0.09%, to 48,416.56, the Nasdaq lost 137.76, or 0.59%, to 23,057.41, and the S&P 500 declined 10.90, or 0.16%, to 6,816.51.

The major averages were lower near noon as markets enter the final full trading week of 2025, with investors responding to recent rally attempts and bouts of tech selloff pressure. Of note, certain AI stocks, including Broadcom and Oracle, were weighing down the broader market.Last week's mixed performance and rotation suggests investors are beginning to weigh earnings fundamentals more heavily than lofty growth multiples. Treasury yields have moved sideways after recent volatility, and risk appetite seems to be stabilizing, but only tentatively, as incoming economic indicators and central-bank decisions in both the U.S. and Europe remain key catalysts.Looking to commodities, gold prices were fractionally higher as the "safe haven" asset once again reaches for record highs. Oil was over 1% lower.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Intelis in discussions to acquire SambaNova for $1.6B,ServiceNowis close to a $7B deal for Armis,CencoraOneOncology from TPGfor $6BiRobotentered into ato be acquired by PiceaLuminarinitiatedand agreed to sell its photonics business to Quantum Computingfor $110M2. WALL STREET CALLS:Texas Instrumentsto Sell from Buy at Goldman SachsAkamaito Overweight from Underweight at KeyBancAdobeto Underweight at KeyBancServiceNowto Underweight at KeyBancGoldman SachsLas Vegas Sands, Marriottand Hiltonto Buy as the firm adjusted ratings in the gaming and lodging group as part of its 2026 outlook3. AROUND THE WEB:Nvidiahas told some Chinese clients that it is evaluating adding production capacity for its H200 AI chips after orders exceeded its output levels,Coca-Colais holding last-ditch discussions with TDR Capital as it attempts to salvage its proposed sale of Costa Coffee,JPMorgan (JPM) advised on and financed a $7.4B deal for Korea Zinc to build the largest zinc smelter in the U.S., aligning with the bank's national security funding strategy,TPGhas exited most of its $600M stake in Anastasia Beverly Hills as part of a debt restructuring,U.S. District Judge George Wu in California ruled Live Nationand its subsidiary Ticketmaster must face a class action for allegedly overcharging its customers for events at major venues across the country,4. MOVERS:Kyverna Therapeuticsincreases after announcing data from itsImmunomegains after announcing its RINGSIDE trial metZIMhigher in New York after announcingshareholders to vote 'FOR' all eight of the company's director nomineesCritical Metalsfalls afterfrom its 2024 drilling program at the Tanbreez Rare Earth ProjectRocket Lablower afterfor JAXA5. EARNINGS/GUIDANCE:Quipt Home Medical, with CEO Gregory Crawford commenting, "Our fiscal 2025 performance underscores both the durability of our model and the accelerating momentum"Highway Holdings, with EPS and revenue lower year-over-yearOcean PowerEdesa Biotech, with EPS missing consensusEnWave (NWVCF), with EPS and revenue higher year-over-yearINDEXES:Near midday, the Dow was down 0.13%, or 64.76, to 48,393.29, the Nasdaq was down 0.29%, or 67.88, to 23,127.30, and the S&P 500 was down 0.06%, or 3.90, to 6,823.51.

Stifel analyst Justin Keywood downgraded Quipt Home Medical to Sell from Buy with a price target of C$5.10, down from C$6.70, after the company announced it is being acquired by private equity managers Kingswood Capital and Forager Capital. The firm's target price adjusts to the take-out offer and although a superior bid could emerge with only a $250,000 break-fee, the firm believes the long duration M&A process has been robust and it sees other undervalued healthcare opportunities existing within its coverage as a "better use of capital," the analyst tells investors.